A novel luminol electrochemiluminescence
(ECL) sensing platform
was developed based on the closed indium tin oxide bipolar electrode
(ITO BPE) for detecting the biomarkers of squamous cell carcinomas
named cytokeratin 19 fragments (CYFRA 21-1). A strategy of in situ-generated coreactant H2O2 and
O2 was proposed to enhance luminol ECL intensity. CaO2, possessing a high capacity of self-supplying H2O2 and O2, was encapsulated by ZIF-67, glucose
oxidase, and horseradish peroxidase (GOD/HRP-loaded ZIF-67@CaO2). In the presence of glucose, gluconic acid and H2O2 were generated via the catalytic effect
of GOD; then, gluconic acid induced the degradation of ZIF-67, leading
to the hydrolysis of the unprotected CaO2 to produce both
O2 and H2O2. Therefore, the generated
coreactants O2 and H2O2, via the oxidation of glucose and the hydrolysis of CaO2, can effectively enhance the luminol ECL behavior. According
to the luminol ECL reaction occurring on the anode surface of the
ITO BPE, a sandwich immunosensor was fabricated on the anodic ITO
BPE and GOD/HRP-loaded ZIF-67@CaO2 as labels incubated
with secondary antibodies. Owing to the cathodic reaction rate influencing
the anodic reaction rate, Au nanoparticles were electrodeposited on
the cathode surface of the ITO BPE, which not only meliorated oxygen
reduction but also further enhanced the ECL intensity of luminol.
Under optimal experiments, an ECL immunosensor for detecting CYFRA
21-1 with a wider linear range from 0.0075 to 50 ng mL–1 and a detection limit of 1.89 pg mL–1 (S/N = 3)
was obtained.